|
John
Babish, Ph.D., is a molecular biologist who served as a tenured Associate
Professor of Pharmacology and Toxicology at Cornell University for 17 years.
He has authored or co-authored over one hundred peer-reviewed scientific
articles, eight position papers, and two book chapters. The inventor of
14 U.S. and world patents, Dr. Babish is the Chairperson of Bionexus®
Ltd. located in Ithaca, New York, the makers of NutriVir®.
Conjugated linoleic acid
(CLA) refers to a group of polyunsaturated fatty acids that exist as positional
and stereoisomers of linoleic acid (conjugated dienoic octadecadienoate
- 18:2 - Figure 1, (1) reviewed in reference number
two (2)). Scientific interest in CLA started in 1979 when Pariza and his
research group at the University of Wisconsin discovered the presence of
“mutagenesis inhibitory” activity in extracts of grilled ground beef. (3)
Later research established that this grilled beef extract exhibited anticancer
activity in mice as well and that the identity of the active principle
was CLA. (4)
Editors’ Note
This issue highlights
original research on the use of a dietary supplement, that includes conjugated
linoleic acid (CLA), in HIV patients exhibiting antiretroviral therapy-associated
lipodystrophy. The two-part article, will help readers to organize and
interpret the body of CLA research. It also presents an overview of the
potential for CLA supplementation in HIV.
The Nutrition Forum column
offers answers to questions on sugar while the Program Spotlight relays
information about the Regional Internal Medicine Clinic located in Spartanburg,
SC.
Book Reviews of Know
Your Fats: The Complete Primer for Understanding the Nutrition of Fats,
Oils, and Cholesterol and the Natural Medicines Comprehensive Database
are noteworthy as well. |
